COPD in the elderly patient.
暂无分享,去创建一个
[1] D. Mannino,et al. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE OLDER ADULT: WHAT BEST DEFINES ABNORMAL LUNG FUNCTION? , 2006 .
[2] H. Dastani,et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. , 2008, Respiratory medicine.
[3] F. Harrell,et al. Dying with Lung Cancer or Chronic Obstructive Pulmonary Disease: Insights from SUPPORT , 2000, Journal of the American Geriatrics Society.
[4] A. Crockett,et al. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.
[5] Joseph Menzin,et al. Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature , 2006, COPD.
[6] Y. Kurokawa,et al. [Lung volume reduction surgery for chronic pulmonary emphysema in elderly patients]. , 2005, Kyobu geka. The Japanese journal of thoracic surgery.
[7] A. Vallejo. Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged , 2006, Immunologic research.
[8] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[9] K. Wood,et al. What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease? , 2008, Drugs & aging.
[10] M. Fiore. AHCPR smoking cessation guideline: a fundamental review. , 1997, Tobacco control.
[11] K. Sullivan,et al. Deciding about mechanical ventilation in end-stage chronic obstructive pulmonary disease: how respirologists perceive their role. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[12] J. Heffner,et al. Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.
[13] D. Mahler,et al. The aging lung. , 1986, Clinics in geriatric medicine.
[14] Carolyn E Behrendt,et al. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. , 2005, Chest.
[15] M. Svartengren,et al. Long-term clearance from small airways decreases with age , 2005, European Respiratory Journal.
[16] D. Patrick,et al. Patient-physician communication about end-of-life care for patients with severe COPD , 2004, European Respiratory Journal.
[17] J. Maurer. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study , 2010 .
[18] P. Barberger‐Gateau,et al. Expiratory flow limitation and obstruction in the elderly , 2005, European Respiratory Journal.
[19] D. Patrick,et al. Association of depression and life-sustaining treatment preferences in patients with COPD. , 2005, Chest.
[20] J. Curtis,et al. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. , 2006, Archives of internal medicine.
[21] T. Fujinaga,et al. Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. , 2005, Chest.
[22] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[23] D. Cook,et al. Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy* , 2007, Critical care medicine.
[24] S. Willsie. A Prospective Clinical Study of Theophylline Safety in 3810 Elderly With Asthma or COPD , 2006 .
[25] Y. Tohda,et al. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. , 2009, Respiratory medicine.
[26] J. Hansen-Flaschen. Chronic obstructive pulmonary disease: the last year of life. , 2004, Respiratory care.
[27] William M Vollmer,et al. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? , 2006, Thorax.
[28] T. Murphy,et al. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. , 2002, Drugs & aging.
[29] L. F. Black,et al. Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .
[30] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[31] D. Mannino,et al. Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.
[32] N. Pride. Ageing and changes in lung mechanics , 2005, European Respiratory Journal.
[33] F. Rengo,et al. Use of Antibiotics in Elderly Patients with Exacerbated COPD: The OLD‐Chronic Obstructive Pulmonary Disease Study , 2006, Journal of the American Geriatrics Society.
[34] J. Carline,et al. Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. , 2002, Chest.
[35] Jiachun Lu,et al. COPD in Chinese nonsmokers , 2009, European Respiratory Journal.
[36] J. Vestbo,et al. COPD: the dangerous underestimate of 15% , 2006, The Lancet.
[37] A. Buist,et al. Reference values for arterial blood gases in the elderly. , 2004, Chest.
[38] D. R. Jones. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial , 2007 .
[39] William M Vollmer,et al. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. , 2005, Respiratory medicine.
[40] D. Mannino. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.
[41] A. Sheikh,et al. Illness trajectories and palliative care , 2005, BMJ : British Medical Journal.
[42] M. Cazzola,et al. The use of bronchodilators in the treatment of airway obstruction in elderly patients. , 2006, Pulmonary pharmacology & therapeutics.
[43] H. Melbye,et al. Lung function testing in the elderly - Can we still use FEV1/FVC < 70% as a criterion of COPD? , 2007 .
[44] P. Ind,et al. Inhaled therapy in elderly COPD patients; time for re-evaluation? , 2007, Age and ageing.
[45] P. Barnes. Future treatments for chronic obstructive pulmonary disease and its comorbidities. , 2008, Proceedings of the American Thoracic Society.
[46] Gulshan Sharma,et al. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.
[47] A. Buist,et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.
[48] A. Agustí. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). , 2007, Proceedings of the American Thoracic Society.
[49] S. Saryal,et al. Differences between asthma and COPD in the elderly. , 2006, Journal of investigational allergology & clinical immunology.
[50] P. Barnes,et al. COPD as a disease of accelerated lung aging(a). , 2009, Revista portuguesa de pneumologia.
[51] Alvar Agusti,et al. Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.